1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Therapy Analysis & Statistics, May 2015 (p4)

Therapy Analysis & Statistics, May 2015 (p4)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

91-120 of about 3 000 reports

Purchase Reports From Reputable Market Research Publishers

Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2015

Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2015

  • $ 2 500
  • Industry report
  • May 2015
  • by Global Data

Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2015" provides data ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Therapy
  • Countries : World
Endotoxemia Global Clinical Trials Review, H1, 2015

Endotoxemia Global Clinical Trials Review, H1, 2015

  • $ 2 500
  • Industry report
  • May 2015
  • by Global Data

Endotoxemia Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Endotoxemia Global Clinical Trials Review, H1, 2015" provides data on the Endotoxemia clinical trial ...

  • Industries : Drug Discovery and Development
  • Countries : World
Myelodysplastic Syndrome - Pipeline Review, H1 2015

Myelodysplastic Syndrome - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Myelodysplastic Syndrome - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Myelodysplastic Syndrome - Pipeline Review, H1 2015’, provides an overview of the Myelodysplastic Syndrome’s ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Bladder Cancer - Pipeline Review, H1 2015

Bladder Cancer - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Bladder Cancer - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Bladder Cancer - Pipeline Review, H1 2015’, provides an overview of the Bladder Cancer’s therapeutic pipeline. This ...

  • Industries : Pathology, Pharmaceutical, General Medicine and Specialty Medicine, Healthcare
  • Countries : United States
Hemophilia A - Pipeline Review, H1 2015

Hemophilia A - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Hemophilia A - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Hemophilia A - Pipeline Review, H1 2015’, provides an overview of the Hemophilia A’s therapeutic pipeline. This report ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States, World
Thrombocytopenia - Pipeline Review, H1 2015

Thrombocytopenia - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Thrombocytopenia - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Thrombocytopenia - Pipeline Review, H1 2015’, provides an overview of the Thrombocytopenia’s therapeutic pipeline. ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015’, provides an ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Cancer Pain - Pipeline Review, H1 2015

Cancer Pain - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Cancer Pain - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Cancer Pain - Pipeline Review, H1 2015’, provides an overview of the Cancer Pain’s therapeutic pipeline. This report provides ...

  • Industries : Pathology, Pharmaceutical, General Medicine and Specialty Medicine, Healthcare
  • Countries : United States
Renal Cell Carcinoma - Pipeline Review, H1 2015

Renal Cell Carcinoma - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Renal Cell Carcinoma - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Renal Cell Carcinoma - Pipeline Review, H1 2015’, provides an overview of the Renal Cell Carcinoma’s therapeutic ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Follicular Lymphoma - Pipeline Review, H1 2015

Follicular Lymphoma - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Follicular Lymphoma - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Follicular Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Follicular Lymphoma’s therapeutic ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2015

Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Diffuse Large B-Cell ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Small-Cell Lung Cancer - Pipeline Review, H1 2015

Small-Cell Lung Cancer - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Small-Cell Lung Cancer - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Small-Cell Lung Cancer - Pipeline Review, H1 2015’, provides an overview of the Small-Cell Lung Cancer’s therapeutic ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015’, provides an overview ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Radiodermatitis - Pipeline Review, H1 2015

Radiodermatitis - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Radiodermatitis - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Radiodermatitis - Pipeline Review, H1 2015’, provides an overview of the Radiodermatitis’s therapeutic pipeline. This ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Chondrosarcoma - Pipeline Review, H1 2015

Chondrosarcoma - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Chondrosarcoma - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Chondrosarcoma - Pipeline Review, H1 2015’, provides an overview of the Chondrosarcoma’s therapeutic pipeline. This report ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Critical Limb Ischemia - Pipeline Review, H1 2015

Critical Limb Ischemia - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • June 2015
  • by Global Markets Direct

Critical Limb Ischemia - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Critical Limb Ischemia - Pipeline Review, H1 2015’, provides an overview of the Critical Limb Ischemia’s therapeutic ...

  • Industries : Pathology, Biological Therapy, Pharmaceutical
  • Countries : United States
Ewing Sarcoma - Pipeline Review, H1 2015

Ewing Sarcoma - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • June 2015
  • by Global Markets Direct

Ewing Sarcoma - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Ewing Sarcoma - Pipeline Review, H1 2015’, provides an overview of the Ewing Sarcoma’s therapeutic pipeline. This report ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Insomnia - Pipeline Review, H1 2015

Insomnia - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • June 2015
  • by Global Markets Direct

Insomnia - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Insomnia - Pipeline Review, H1 2015’, provides an overview of the Insomnia’s therapeutic pipeline. This report provides comprehensive ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Malignant Pleural Mesothelioma - Pipeline Review, H1 2015

Malignant Pleural Mesothelioma - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • May 2015
  • by Global Markets Direct

Malignant Pleural Mesothelioma - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Malignant Pleural Mesothelioma - Pipeline Review, H1 2015’, provides an overview of the Malignant Pleural ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Diabetic Foot Ulcers - Pipeline Review, H1 2015

Diabetic Foot Ulcers - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • May 2015
  • by Global Markets Direct

Diabetic Foot Ulcers - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Diabetic Foot Ulcers - Pipeline Review, H1 2015’, provides an overview of the Diabetic Foot Ulcers’s therapeutic ...

  • Industries : Medical Equipment and Supply, Medical Devices, Pathology, Pharmaceutical
  • Countries : United States
Klebsiella Pneumoniae Infections - Pipeline Review, H1 2015

Klebsiella Pneumoniae Infections - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • May 2015
  • by Global Markets Direct

Klebsiella Pneumoniae Infections - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Klebsiella Pneumoniae Infections - Pipeline Review, H1 2015’, provides an overview of the Klebsiella ...

  • Industries : Research and Development, Drug and Medication, Pharmaceutical
  • Countries : United States
Gouty Arthritis (Gout) - Pipeline Review, H1 2015

Gouty Arthritis (Gout) - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • May 2015
  • by Global Markets Direct

Gouty Arthritis (Gout) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Gouty Arthritis (Gout) - Pipeline Review, H1 2015’, provides an overview of the Gouty Arthritis (Gout)’s therapeutic ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Hemophilia B - Pipeline Review, H1 2015

Hemophilia B - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • May 2015
  • by Global Markets Direct

Hemophilia B - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Hemophilia B - Pipeline Review, H1 2015’, provides an overview of the Hemophilia B’s therapeutic pipeline. This report ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Acromegaly - Pipeline Review, H1 2015

Acromegaly - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • May 2015
  • by Global Markets Direct

Acromegaly - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Acromegaly - Pipeline Review, H1 2015’, provides an overview of the Acromegaly’s therapeutic pipeline. This report provides ...

  • Industries : Pharmaceutical, Drug and Medication, Pathology
  • Countries : United States, World
Brain Metastasis - Pipeline Review, H1 2015

Brain Metastasis - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • May 2015
  • by Global Markets Direct

Brain Metastasis - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Brain Metastasis - Pipeline Review, H1 2015’, provides an overview of the Brain Metastasis’s therapeutic pipeline. ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Neutropenia - Pipeline Review, H1 2015

Neutropenia - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • May 2015
  • by Global Markets Direct

Neutropenia - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Neutropenia - Pipeline Review, H1 2015’, provides an overview of the Neutropenia’s therapeutic pipeline. This report provides ...

  • Industries : Pharmaceutical, Biological Therapy, Research and Development
  • Countries : United States
Malignant Mesothelioma - Pipeline Review, H1 2015

Malignant Mesothelioma - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • May 2015
  • by Global Markets Direct

Malignant Mesothelioma - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Malignant Mesothelioma - Pipeline Review, H1 2015’, provides an overview of the Malignant Mesothelioma’s therapeutic ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Endometrial Cancer - Pipeline Review, H1 2015

Endometrial Cancer - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • May 2015
  • by Global Markets Direct

Endometrial Cancer - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Endometrial Cancer - Pipeline Review, H1 2015’, provides an overview of the Endometrial Cancer’s therapeutic pipeline. ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Epithelial Ovarian Cancer - Pipeline Review, H1 2015

Epithelial Ovarian Cancer - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • May 2015
  • by Global Markets Direct

Epithelial Ovarian Cancer - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Epithelial Ovarian Cancer - Pipeline Review, H1 2015’, provides an overview of the Epithelial Ovarian Cancer’s ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Diabetic Retinopathy - Pipeline Review, H1 2015

Diabetic Retinopathy - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • May 2015
  • by Global Markets Direct

Diabetic Retinopathy - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Diabetic Retinopathy - Pipeline Review, H1 2015’, provides an overview of the Diabetic Retinopathy’s therapeutic ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.